Cargando…

Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances

Indomethacin (IND) is a drug which after successful clinical trials became available for general prescription in 1965 and from that time is one of the most widely used anti-inflammatory drug with the highest potencies in the in vitro and in vivo models. However, despite its high therapeutic efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gliszczyńska, Anna, Nowaczyk, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998224/
https://www.ncbi.nlm.nih.gov/pubmed/33809343
http://dx.doi.org/10.3390/molecules26061576